Ovid Therapeutics Inc. (OVID) NASDAQ
1.97
-0.04(-1.99%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.97
-0.04(-1.99%)
Currency In USD
| Market Cap | 66.2M |
| Enterprise Value | 54.66M |
| P/E Ratio | -3.86 |
| PEG Ratio | -0.69 |
| Price/Sales Ratio | 21.22 |
| Price/Book Ratio | 3.13 |
| Enterprise/Revenue | 20.19 |
| Enterprise/EBITDA | -3.31 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | -5.5 |
| Operating Margin | -6.18 |
| Return On Assets | -0.57 |
| Return On Equity | -0.64 |
| Revenue | 566,000 |
| Revenue/Share | 0.09 |
| Gross Profit | 566,000 |
| EBITDA | -57.77M |
| Net Income | -26.43M |
| Diluted EPS | -0.37 |
| Total Cash | 25.6M |
| Total Cash/Share | 0.36 |
| Total Debt | 13.76M |
| Total Debt/Equity | 0.31 |
| Current Ratio | 4.24 |
| Book Value Per Share | 0.63 |
| 52-Week Change | 354.02 |
| 52-Week High | 2.37 |
| 52-Week Low | 0.24 |
| Moving Average 50 Days | 1.66 |
| Moving Average 200 Days | 1.21 |
| Average Volume | 1.64M |
| Shares Outstanding | 71.21M |
| % Held by Institutions | 87.01 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |